AU5457694A - Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis - Google Patents

Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

Info

Publication number
AU5457694A
AU5457694A AU54576/94A AU5457694A AU5457694A AU 5457694 A AU5457694 A AU 5457694A AU 54576/94 A AU54576/94 A AU 54576/94A AU 5457694 A AU5457694 A AU 5457694A AU 5457694 A AU5457694 A AU 5457694A
Authority
AU
Australia
Prior art keywords
doxazosin
atherosclerosis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54576/94A
Inventor
Nancy M. Gray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU5457694A publication Critical patent/AU5457694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
AU54576/94A 1992-11-04 1993-11-02 Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis Abandoned AU5457694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97141292A 1992-11-04 1992-11-04
US971412 1992-11-04
PCT/US1993/010577 WO1994009783A1 (en) 1992-11-04 1993-11-02 Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

Publications (1)

Publication Number Publication Date
AU5457694A true AU5457694A (en) 1994-05-24

Family

ID=25518349

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54576/94A Abandoned AU5457694A (en) 1992-11-04 1993-11-02 Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

Country Status (2)

Country Link
AU (1) AU5457694A (en)
WO (1) WO1994009783A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0849265A1 (en) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Novel polymorphic form of doxazosin mesylate (form II)
DK0849266T3 (en) * 1996-12-20 2007-06-04 Heumann Pcs Gmbh New polymorphic form of doxazosin mesylate (form III)
EP0849264A1 (en) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Novel polymorphic form of doxazosin mesylate (form I)
DE19800214A1 (en) * 1998-01-06 1999-07-15 Knoll Ag Process for the preparation of doxazosin mcsylate in a crystal modification referred to as Form A and an intermediate therefor
CN102321078B (en) * 2005-11-11 2013-08-28 华北制药集团新药研究开发有限责任公司 Doxazosin mesylate III form crystal, and preparation method and usage thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines

Also Published As

Publication number Publication date
WO1994009783A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
IL101243A0 (en) Pharmaceutical compositions for treatment of benign prostatic hyperplasia
EP0667769A4 (en) Use of alpha-1c specific compounds to treat benign prostatic hyperplasia.
IL130762A0 (en) Quinoline and quinazoline compounds useful in therapy particularly in the treatment of benign prostatic hyperplasia
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
IL101574A0 (en) Combination pharmaceutical compositions for the treatment of benign prostatic hyperplasia
AU1751795A (en) Liposome compositions and methods for the treatment of atherosclerosis
AU4890997A (en) Rayleigh-breakup atomizing devices and methods of making rayleigh-breakup atomizing devices
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
ZA952763B (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
AU9016898A (en) Methods and compositions for treatment of restenosis
HU9501286D0 (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AU2821295A (en) Compositions and methods for the treatment of tumors
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
IL137954A0 (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
EP0633781A4 (en) Compositions and methods for treating benign prostatic hypertrophy.
AU4816896A (en) Treatment and prevention of prostatic cancer
AU5984196A (en) Treatment and prevention of prostatic disease
AU6374798A (en) Methods and compositions of (+) doxazosin for the treatment of hypertension and benign prostatic hyperplasia
EP0748627A3 (en) Melatonin agonists for use in the treatment of benign prostatic hyperplasia
AUPO410796A0 (en) Method of treating benign prostatic hyperplasia
AU5546294A (en) Methods and compositions of (-) doxazosin for the treatment of hypertension
ZA922010B (en) Improved method of treatment for benign prostatic hyperplasia